Online Educational Program Will Address Impact of Tax Reform Bills on Health Care
Nov 20, 2017 15:03 pm UTC| Business
Washington, D.C., Nov. 20, 2017 -- The impacts of the House and Senate tax reform bills on 501(c)(3) hospitals and health systems and other tax-exempt organizations will be explored in a November 28 webinar to be...
OnTerra Systems Introduces New Version of MapSavvy Web Map Service
Nov 20, 2017 15:01 pm UTC| Business
DENVER, Nov. 20, 2017 -- OnTerra Systems today introduced a new version of its MapSavvy aerial imagery service and a corresponding new website: www.MapSavvy.com. MapSavvy is an affordable Web Map Service providing...
Ability Network Named Winner at 18th Annual Tekne Awards
Nov 20, 2017 15:00 pm UTC| Business
MINNEAPOLIS, Nov. 20, 2017 -- The Minnesota High Tech Association (MHTA) has named ABILITY® Network, a leading healthcare information technology company, winner in the Software (established company) category for the...
Nov 20, 2017 15:00 pm UTC| Business
New York, NY, Nov. 20, 2017 -- The “I Have A Dream” Foundation has received over $30,000 in donations from 150 people in memory of Tommaso Cerase, a nine year old boy who died in a tragic accident during a Juventus...
UPS Dramatically Increases Use Of Renewable Natural Gas
Nov 20, 2017 15:00 pm UTC| Business
UPS Agreement for 10 Million Gallon Equivalents a Year with Big Ox Energy is its Largest Commitment to Date ATLANTA, Nov. 20, 2017 -- UPS (NYSE: UPS) today announced an agreement with Big Ox Energy (a wholly owned...
ITRI Receives Eight 2017 R&D 100 Awards and an R&D 100 Special Recognition Award
Nov 20, 2017 15:00 pm UTC| Business
HSINCHU, Taiwan, Nov. 20, 2017 -- The Industrial Technology Research Institute (ITRI), Taiwan’s largest and one of the world’s leading high-tech applied research institutions, received eight 2017 RD 100 Awards and one...
Spero Therapeutics, Inc. (Nasdaq: SPRO) to Ring The Nasdaq Stock Market Closing Bell
Nov 20, 2017 15:00 pm UTC| Business
ADVISORY, Nov. 20, 2017 -- What:Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug...